Certain MPN phenotypes are associated with specific driving mutations or/and mutant allele burden, but none can be explained solely by the patient’s JAK2V617F load nor by the presence of CALR or MPL mutation(s). This evidence concerns the gene CALR and myeloproliferative neoplasm.